We are live on ! Find out more
Renaissance Technologies

Renaissance Technologies Portfolio holdings

AUM $63.9B
1-Year Est. Return 45.56%
 

Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.

This Fund
S&P 500
This Quarter Est. Return
+8.19%
1 Year Est. Return
+45.56%
3 Year Est. Return
+129.95%
5 Year Est. Return
+153.6%
10 Year Est. Return
+738.07%
AUM
$73.1B
AUM Growth
+$2.4B
Cap. Flow
-$1.43B
Cap. Flow %
-1.96%
Top 10 Hldgs %
11.25%
Holding
4,601
New
626
Increased
1,390
Reduced
2,018
Closed
524

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$839M
2
AMZN icon
Amazon
AMZN
+$810M
3
TSLA icon
Tesla
TSLA
+$644M
4
TSM icon
TSMC
TSM
+$546M
5
JNJ icon
Johnson & Johnson
JNJ
+$389M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$891M
2
HD icon
Home Depot
HD
+$441M
3
JPM icon
JPMorgan Chase
JPM
+$335M
4
NVO
Novo Nordisk
NVO
+$317M
5
ASML icon
ASML
ASML
+$315M

Sector Composition

Rank Sector Weight
1 Healthcare 20.81%
2 Technology 15.51%
3 Consumer Discretionary 11.84%
4 Consumer Staples 10.09%
5 Financials 9.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XHG
3801
XChange TEC
XHG
$49M
$49K ﹤0.01%
1
SHPW
3802
DELISTED
Shapeways Holdings, Inc. Common Stock
SHPW
$49K ﹤0.01%
11,375
-14,688
-56% -$69.7K
CXDO icon
3803
Crexendo
CXDO
$244M
$48K ﹤0.01%
+25,437
New +$56.5K
RGLS
3804
DELISTED
Regulus Therapeutics
RGLS
$48K ﹤0.01%
34,800
+2,400
+7% +$3.77K
BNKK
3805
Bonk Inc
BNKK
$8.4M
$48K ﹤0.01%
+1,800
New +$60.9K
VANI icon
3806
Vivani Medical
VANI
$120M
$48K ﹤0.01%
+56,600
New +$92.2K
PTE
3807
DELISTED
PolarityTE, Inc. Common Stock
PTE
$48K ﹤0.01%
73,922
+6,700
+10% +$4.88K
IMNM icon
3808
Immunome
IMNM
$2.83B
$47K ﹤0.01%
21,100
-400
-2% -$1.61K
XTKG
3809
DELISTED
X3 Holdings Co., Ltd. Class A Ordinary Shares
XTKG
$47K ﹤0.01%
+1
New +$126K
QNTM
3810
Quantum Biopharma Class B Subordinate Voting Shares
QNTM
$18.9M
$47K ﹤0.01%
911
-7
-0.8% -$387
ENFY
3811
DELISTED
Enlightify Inc
ENFY
$46K ﹤0.01%
11,451
-600
-5% -$3.2K
UFAB
3812
DELISTED
Unique Fabricating, Inc.
UFAB
$46K ﹤0.01%
82,577
-3,900
-5% -$2.21K
THRN
3813
DELISTED
Thorne Healthtech, Inc. Common Stock
THRN
$46K ﹤0.01%
12,800
+500
+4% +$2.22K
CFRX
3814
DELISTED
ContraFect Corporation
CFRX
$46K ﹤0.01%
5,974
+4,390
+277% +$50.8K
GNS icon
3815
Genius Group
GNS
$31.5M
$45K ﹤0.01%
+13,720
New +$124K
YCBD icon
3816
cbdMD
YCBD
$5.89M
$45K ﹤0.01%
554
+35
+7% +$3.52K
FATH
3817
DELISTED
Fathom Digital Manufacturing Corporation
FATH
$45K ﹤0.01%
1,705
-1,315
-44% -$57.4K
LMFA
3818
DELISTED
LM Funding America
LMFA
$44K ﹤0.01%
527
-627
-54% -$74.7K
SOPH icon
3819
SOPHiA GENETICS
SOPH
$549M
$44K ﹤0.01%
21,500
+2,500
+13% +$5.61K
BSIN
3820
Big Sky Industrial
BSIN
$61.2M
$44K ﹤0.01%
+19,200
New +$51.8K
NVOS
3821
DELISTED
Novo Integrated Sciences, Inc. Common Stock
NVOS
$44K ﹤0.01%
+21,925
New +$75.4K
VCSA
3822
DELISTED
Vacasa, Inc. Class A Common Stock
VCSA
$44K ﹤0.01%
1,730
-30,732
-95% -$1.43M
NBRV
3823
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$44K ﹤0.01%
23,061
+2,500
+12% +$5.52K
SBDS
3824
DELISTED
Solo Brands Inc
SBDS
$44K ﹤0.01%
+293
New +$47.9K
MRKR icon
3825
Marker Therapeutics
MRKR
$21.2M
$43K ﹤0.01%
16,320
+1,170
+8% +$4.04K

Similar funds

Renaissance Technologies's Q4 2022 Portfolio in Review

As of Q4 2022, Renaissance Technologies held 4,601 positions worth $73.1B, up 3.4% from $70.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Renaissance Technologies's Q4 2022 filing shows 626 new, 1,390 increased, 2,018 reduced and 524 closed positions. Its largest new stake was Johnson & Johnson: 2,254,125 shares worth $398M. The largest sale was Microsoft, an estimated $891M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Renaissance Technologies's largest Q4 2022 buy was Johnson & Johnson: 2,254,125 shares worth $398M.
  • Renaissance Technologies added most to Apple in Q4 2022, an estimated $839M increase.
  • Renaissance Technologies's biggest Q4 2022 reduction was Novo Nordisk, cutting an estimated $317M.
  • Renaissance Technologies fully exited Microsoft in Q4 2022, selling an estimated $891M.
  • Renaissance Technologies's ten largest holdings make up 11% of its $73.1B portfolio in Q4 2022.
  • Renaissance Technologies opened 626 new positions and closed 524 in Q4 2022.
  • Renaissance Technologies's portfolio value rose 3.4% quarter-over-quarter to $73.1B.

Based on Renaissance Technologies's 13F filing for Q4 2022, filed 13 Feb 2023.